Updates on BTK Inhibitors and Multiple Sclero...

In part one of this series, Drs. Shuvro Roy, Jiwon Oh, and Amit Bar-Or discuss the results of the fenebrutinib trial and highlight the key takeaways that healthcare providers should be aware of. For more information, please read about the abstract that was presented at the 2026 A ...  Show more

In part one of this series, Dr. Halley Alexander and Dr. Heidi Munger Clary discuss the best methods for screening patients with epilepsy in a clinical setting. Show citations: Mula M, Brodie MJ, de Toffol B, et al. ILAE clinical practice recommendations for the medical treatment ...  Show more

In the concluding segment of this two-part series, Dr. Justin Abbatemarco talks with Dr. Jennifer L. Orthmann-Murphy about genetic leukodystrophies and the increasing recognition of these disorders in adult neurology, the importance of genetic testing, and the evolving treatment ...  Show more

Dr. Andy Southerland talks with Dr. Andrea Lendaris about her experience of having Usher syndrome type 2A along with her journey of having acute and chronic health challenges.  This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information. Disclosures can be ...  Show more

Dr. Derek Stitt talks with Dr. Karin Diserens about subtle signs and motor behavior to unveil awareness in unresponsive brain-impaired individuals.

Read the related article in <a href= "https://n.neurology.org/content/early/2023/02/28/WNL.0000000000207067" target="_blan ...

Dr. Halley Alexander talks with Dr. Vineet Punia about factors influencing the decision to continue or discontinue anti-seizure medications at discharge for patients hospitalized with acute symptomatic seizures.  Read the related article in JAMA.   Disclosures can be found at Neu ...  Show more